Less than six months after Nasdaq debut, Malaysia’s Alps Group pivots to bridge biotech access gap April 20, 2026
Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight April 17, 2026
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy February 9, 2026
